COVID-19 testing and treatment update (March 2022)
The Governament has updated it’s guidance for higher risk patients, which includes many haemoglobinopathy patients.
Click here to view the patient guidance and information document (doc ref C1615).
For Clinicians, please click here (doc ref C1613) and here (doc ref C1614) for more information about your high-risk patients .
For more information on COVID-19 treatments, view information on the linked NHS webpage.
Patient information on COVID-19 in haemoglobinopathy and rare inherited anaemias patients (February 2020)
This document provides a summary of information on frequency and severity of COVID-19 infections in patients with haemoglobinopathies and rare inherited anaemias, including information on numbers of patients affected and hospitalized and clinical outcomes for patients admitted to hospital. This information has been produced by a group of clinicians within the Panel collaborating on the national response to COVID-19.
Click here to view the guidance and information document.
Haemoglobinopathy and COVID-19: what’s my risk?
This infographic produced by the NHP in collaboration with the Sickle Cell Society offers a concise guide on levels of risk associated with haemoglobinopathy patients contracting COVID-19.
Click here to view the infographic.
Updated guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19
The guidance has been updated in light of the move to a Tier 4 lockdown for much of the UK population resulting from the recent rise in COVID-19 cases and admissions
Updated advice on shielding and protecting clinically extremely vulnerable persons from COVID-19 (December 2020)
The Department of Health and Social Care and Public Health England have published new guidance in light of the end of the second UK lockdown and return to the Tier system.
Updated advice to clinicians regarding COVID-19 in patients with haemoglobinopathies and inherited rare anaemias (November 2020)
Click the link below to read the most current advice from the NHP and the Haemoglobinopathy Co-ordinating Centres on management of COVID-19 in haemoglobinopathy patients.
Updated advice to clinicians regarding COVID-19 in patients with haemoglobinopathies and inherited rare anaemias
Click the link below to read the latest advice from the NHP and the Haemoglobinopathy Co-ordinating Centres on management of COVID-19 in haemoglobinopathy patients.
